Qube Research & Technologies Ltd - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$780,061
+97.3%
78,556
+38.3%
0.00%
+50.0%
Q4 2022$395,460
+107.0%
56,819
+59.0%
0.00%
+100.0%
Q3 2022$191,000
+148.1%
35,728
+84.0%
0.00%0.0%
Q2 2022$77,000
-79.8%
19,415
-55.3%
0.00%
-80.0%
Q3 2021$382,000
-30.4%
43,459
-10.4%
0.01%
-16.7%
Q2 2021$549,000
-19.6%
48,498
-15.7%
0.01%
-45.5%
Q1 2021$683,000
-34.6%
57,502
-62.2%
0.01%
-26.7%
Q4 2020$1,044,000
+221.2%
152,189
+246.8%
0.02%
+200.0%
Q3 2020$325,000
+277.9%
43,886
+112.7%
0.01%
+400.0%
Q2 2020$86,00020,6300.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 484,096$6,317,0005.34%
CVI Holdings, LLC 200,000$2,760,0004.56%
Mesirow Financial Investment Management, Inc. 38,097$526,0002.71%
SPHERA FUNDS MANAGEMENT LTD. 1,142,089$15,761,0001.81%
683 Capital Management, LLC 1,350,000$18,630,0001.21%
Stonepine Capital Management, LLC 145,000$2,001,0001.17%
Perceptive Advisors 3,085,458$42,579,0001.14%
EAM Investors, LLC 312,092$4,307,0000.64%
MANGROVE PARTNERS IM, LLC 707,746$9,767,0000.62%
EAM Global Investors LLC 86,614$1,195,0000.48%
View complete list of ALDEYRA THERAPEUTICS INC shareholders